SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Guilford (GLFD) - Steadily Rising
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
496 22 0 GLFD
Emcee:  Jim Ball Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
371Analyst Recommendations? "CIBC World Markets said on Friday that it is cutMark Bong-8/12/2000
370<i>Analyst Matt Geller of CIBC World Markets is impressed by Guilford'Biomaven-8/12/2000
369Guilford Perks Up Does this biotech have a blockbuster Parkinson's drug? NMark Bong-8/11/2000
368Tuck, Apparently the phase I was in healthy volunteers. They obviously spent timVector1-8/11/2000
367Vector1, I've been following several companies that deal with neurodegeneratuck-8/11/2000
366At least this kind of PR, beyond causing a short lived pop in price, should brinVinnie-8/11/2000
365Guilford Perks Up Does this biotech have a blockbuster Parkinson's drug? sim1-8/11/2000
36407:12 ET Business Week Stock : Guilford Pharmaceuticals (GLFD 17 1/2) may have aJack Hartmann-8/11/2000
363Thanks...that gives me some feel for the time schedule to expect....Vinnie-8/9/2000
362Vinnie, it depends on the indication. How long it takes the drug to effect the dVector1-8/9/2000
361How long does it typically take to complete such a Phase II evaluation? For thatVinnie-8/8/2000
360Nigel, this is excellent news. Positive phase II data would result in a major moVector1-8/7/2000
3597 /PRNewswire/ -- Guilford Pharmaceuticals (Nasdaq: GLFD - news) announced todaynigel bates-8/7/2000
358now if they can get it into phase III next year, we might have something to lookVinnie-7/28/2000
357News from Amgen <i>Amgen and its partner Guilford Pharmaceuticals have alsim1-7/27/2000
356Here is the link to the Forbes GLFD article: forbes.comRCMac-7/25/2000
355favorable article on GLFD in the Aug 7, 2000 issue of Forbes, technology sectionBill Tomko-7/24/2000
354 Well, I think the selling has stopped and bought some GLFD today. Good luck to Jack Hartmann-6/9/2000
353 <i>Anyhow, curious about your take</i> Tuck, I like the deal. Both Jack Hartmann-6/6/2000
352 Bill, I don't think anyone asked me for my thoughts, recently, but since ytuck-6/6/2000
351 I too would be interested in your thoughts on GLFD. I'm a long time holder Bill Tomko-6/6/2000
350 Jack, Since you've owned both, maybe you have a take on the issue that contuck-6/5/2000
349 <i>Here come the new lows and buying op in a few months</i> I agreeJack Hartmann-5/30/2000
348 Steve, GLFD munches GLIA! siliconinvestor.com Here come the new lows and buytuck-5/30/2000
347 Great Howard! Please let me know what else he likes. take care, steveSteve Smith-3/4/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News